Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 11:11 PM
Study NCT ID:
NCT00518193
Status:
TERMINATED
Last Update Posted:
2011-06-30
First Post:
2007-08-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix
Sponsor:
ARCAGY/ GINECO GROUP
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ERBUS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Frédéric MARMION
Old Organization:
ARCAGY-GINECO